Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Survival of patients with multiple sclerosis in Denmark : a nationwide, long-term epidemiologic survey. / Brønnum-Hansen, Henrik; Koch-Henriksen, Nils; Hyllested, K.
In: Neurology, Vol. 44, No. 10, 1994, p. 1901-7.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Survival of patients with multiple sclerosis in Denmark
T2 - a nationwide, long-term epidemiologic survey
AU - Brønnum-Hansen, Henrik
AU - Koch-Henriksen, Nils
AU - Hyllested, K
PY - 1994
Y1 - 1994
N2 - We estimated survival probability and excess death rates for patients with MS on the basis of data from the Danish Multiple Sclerosis Registry, which includes virtually all patients diagnosed with MS in Denmark (population, five million) since 1948. We reviewed and reclassified all case records according to standardized diagnostic criteria. By linkage to the Danish Central Population Registry, we lost to follow-up only 25 patients who had emigrated. The median survival time from onset of the disease was 28 years in men (compared with 40 years in the matched general male population) and 33 years in women (versus 46 years). The median survival time from diagnosis was 22 years in men (versus 37 years) and 28 years in women (versus 42 years). The excess death rate between onset and follow-up (observed deaths per 1,000 person-years minus the expected number of deaths in a matched general population) was 14.3 in men, which was significantly higher than in women (12.0). Excess mortality increased with age at onset of MS in people of each sex. The 10-year excess death rate has decreased significantly in recent decades. Excess mortality was highest in cases with cerebellar symptoms at onset.
AB - We estimated survival probability and excess death rates for patients with MS on the basis of data from the Danish Multiple Sclerosis Registry, which includes virtually all patients diagnosed with MS in Denmark (population, five million) since 1948. We reviewed and reclassified all case records according to standardized diagnostic criteria. By linkage to the Danish Central Population Registry, we lost to follow-up only 25 patients who had emigrated. The median survival time from onset of the disease was 28 years in men (compared with 40 years in the matched general male population) and 33 years in women (versus 46 years). The median survival time from diagnosis was 22 years in men (versus 37 years) and 28 years in women (versus 42 years). The excess death rate between onset and follow-up (observed deaths per 1,000 person-years minus the expected number of deaths in a matched general population) was 14.3 in men, which was significantly higher than in women (12.0). Excess mortality increased with age at onset of MS in people of each sex. The 10-year excess death rate has decreased significantly in recent decades. Excess mortality was highest in cases with cerebellar symptoms at onset.
KW - Adult
KW - Age of Onset
KW - Denmark
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Incidence
KW - Male
KW - Middle Aged
KW - Multiple Sclerosis
KW - Proportional Hazards Models
KW - Prospective Studies
KW - Registries
KW - Sex Factors
KW - Survival Analysis
KW - Survival Rate
M3 - Journal article
C2 - 7936244
VL - 44
SP - 1901
EP - 1907
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 10
ER -
ID: 44174517